Bunting et al v. AbbVie Inc. et al
| Juliana A. Bunting |
| AbbVie Inc., Abbott Laboratories, AbbVie Products LLC, Unimed Pharmaceuticals, LLC, SOLVAY, S.A., Besins Healthcare, Inc, Besins Healthcare, S.A., Actavis PLC, Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., Watson Laboratories, Inc. and Anda, Inc. |
| 2:2023cv04220 |
| November 29, 2023 |
| US District Court for the Western District of Missouri |
| Beth Phillips |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Product Liability |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 27, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 93 REPLY SUGGESTIONS to motion re #79 MOTION for reconsideration on Punitive Damages Ruling filed by James Griffin O'Brien on behalf of Plaintiffs Juliana A. Bunting, Juliana A. Bunting. (Attachments: #1 Exhibit A - AbbVie MSJ Reply (re 7 MDL bellwethers), #2 Exhibit B - AbbVie MSJ Memo (re Loreto), #3 Exhibit C - AbbVie MSJ Reply (re Loreto))(Related document(s) #79 ) (O'Brien, James) |
Filing 92
ORDER granting #91 motion to appear pro hac vice entered by Clerk of Court. Attorney James G. O'Brien for All Plaintiffs allowed to appear pro hac vice. This entry will serve as authorization for the pro hac participation by the attorney. Western District of Missouri Local Rule 5.1 requires documents to be filed electronically. If pro hac vice counsel has not already done so, counsel is directed to immediately register for a WDMO e-filing account for NextGen CM/ECF. This will enable counsel to electronically file documents and receive electronic notification of filings. Register for a WDMO e-filing account at #PACER. This is a TEXT ONLY ENTRY. No document is attached. (Warren, Melissa)
|
| Filing 91 Motion to allow James G. O'Brien to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8767868) filed by Brett A. Emison on behalf of All Plaintiffs. (Emison, Brett) |
| Filing 90 DISCLOSURE OF CORPORATE INTERESTS filed by Andrew J Rima on behalf of Respondents AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC.(Rima, Andrew) |
|
Filing 89
ORDER granting #88 motion to appear pro hac vice entered by Clerk of Court. Attorney Stefani L. Wittenauer for AbbVie Inc. allowed to appear pro hac vice. This entry will serve as authorization for the pro hac participation by the attorney. Western District of Missouri Local Rule 5.1 requires documents to be filed electronically. If pro hac vice counsel has not already done so, counsel is directed to immediately register for a WDMO e-filing account for NextGen CM/ECF. This will enable counsel to electronically file documents and receive electronic notification of filings. Register for a WDMO e-filing account at #PACER. This is a TEXT ONLY ENTRY. No document is attached. (Berner, Crystal)
|
| Filing 88 Motion to allow Stefani L. Wittenauer to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8758962) filed by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC. (Ball, Dan) |
| Filing 87 SUGGESTIONS in opposition re #79 MOTION for reconsideration on Punitive Damages Ruling filed by Andrew J Rima on behalf of Respondents AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC. Reply suggestions due by 12/27/2023 unless otherwise directed by the court. (Attachments: #1 Declaration of Andrew Rima, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C)(Related document(s) #79 ) (Rima, Andrew) |
|
Filing 86
ORDER granting #81 , #82 , #83 , #84 & #85 motions to appear pro hac vice entered by Clerk of Court. Attorneys Andrew J Rima, Marie Notter, Edward J. Dumoulin, Michael James Casner & Shayna S. Cook for AbbVie Inc.; AbbVie Products LLC; Abbott Laboratories; Actavis Laboratories UT, Inc.; Actavis PLC; Actavis Pharma, Inc.; Actavis, Inc.; Anda, Inc.; Besins Healthcare, Inc; Besins Healthcare, S.A.; SOLVAY, S.A.; Unimed Pharmaceuticals, LLC; and Watson Laboratories, Inc. allowed to appear pro hac vice. This entry will serve as authorization for the pro hac participation by the attorney. Western District of Missouri Local Rule 5.1 requires documents to be filed electronically. If pro hac vice counsel has not already done so, counsel is directed to immediately register for a WDMO e-filing account for NextGen CM/ECF. This will enable counsel to electronically file documents and receive electronic notification of filings. Register for a WDMO e-filing account at #PACER. This is a TEXT ONLY ENTRY. No document is attached. (Lock, Tania)
|
| Filing 85 Motion to allow Marie Notter to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8748598) filed by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC. (Ball, Dan) |
| Filing 84 Motion to allow Shayna S. Cook to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8748583) filed by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC. (Ball, Dan) |
| Filing 83 Motion to allow Michael James Casner to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8748562) filed by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC. (Ball, Dan) |
| Filing 82 Motion to allow Edward James Dumoulin to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8748545) filed by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC. (Ball, Dan) |
| Filing 81 Motion to allow Andrew J. Rima to appear pro hac vice (Pro Hac fee $100 receipt number AMOWDC-8748503) filed by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC. (Ball, Dan) |
| Filing 80 NOTICE of appearance by Dan H. Ball on behalf of AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Besins Healthcare, Inc, Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC (Attorney Dan H. Ball added to party AbbVie Inc. (pty:res), Attorney Dan H. Ball added to party AbbVie Products LLC(pty:res), Attorney Dan H. Ball added to party Abbott Laboratories(pty:res), Attorney Dan H. Ball added to party Besins Healthcare, Inc(pty:res), Attorney Dan H. Ball added to party Besins Healthcare, S.A.(pty:res), Attorney Dan H. Ball added to party SOLVAY, S.A. (pty:res), Attorney Dan H. Ball added to party Unimed Pharmaceuticals, LLC(pty:res))(Ball, Dan) |
| Filing 79 MOTION for reconsideration on Punitive Damages Ruling filed by Brett A. Emison on behalf of All Plaintiffs. Suggestions in opposition/response due by 12/13/2023 unless otherwise directed by the court. (Emison, Brett) |
| Filing 78 NOTICE of appearance by Brett A. Emison on behalf of All Plaintiffs (Attorney Brett A. Emison added to party Juliana A. Bunting(pty:pla), Attorney Brett A. Emison added to party Juliana A. Bunting(pty:pla))(Emison, Brett) |
| Filing 77 NOTICE OF INCLUSION FOR MEDIATION AND ASSESSMENT PROGRAM (MAP). REVIEW NOTICE AND MAP GENERAL ORDER CAREFULLY FOR IMPORTANT CHANGES, DEADLINES AND REQUIREMENTS.Notice of MAP assignment to outside neutral category I. (Attachments: #1 MAP General Order)(Warren, Melissa) |
| Filing 76 CASE TRANSFERRED IN from District of Illinois Northern; Case Number 1:15-cv-09699. |
| Filing 75 TRANSFERRED to the Western District of Missouri the electronic record. (rp, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 74 CASE MANAGEMENT ORDER NO. 197. Transfer order for all remaining cases. Signed by the Honorable Matthew F. Kennelly on 11/27/2023. Mailed notice (rp, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 73 RELEVANT ORDERS FROM MDL PROCEEDING, entered by the Honorable Matthew F. Kennelly on 11/26/2023: (Attachments: #1 Supplement Protective Order (Amended), #2 Supplement Direct Filing Order, #3 Supplement Master Pleadings Order, #4 Supplement Deposition Protocol Order, #5 Supplement Order re Sequence of Bellwether Trial, #6 Supplement Order Appointing Settlement Master, #7 Supplement Docket Control Order for Future Cases, #8 Supplement Application of CMO 126 to Future Cases, #9 Supplement Konrad/Mitchell MIL rulings, #10 Supplement Holtsclaw MIL rulings, #11 Supplement Nolte MIL rulings, #12 Supplement Myers MIL rulings, #13 Supplement Rowley MIL rulings, #14 Supplement Martin MIL rulings, #15 Supplement Martin trial time limits order) (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 72 MDL CASE MANAGEMENT ORDER NO. 195 (Order on AbbVie's motions to exclude expert testimony and motions for summary judgment in Bunting v. AbbVie Inc., No. 15 C 9699 and Reynolds v. AbbVie Inc., No. 17 C 4117), signed by the Honorable Matthew F. Kennelly on 11/1/2023. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 71 REPLY by Defendants AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC to motion for summary judgment, #62 Reply in support of AbbVie's Motion for Summary Judgment (Attachments: #1 Declaration of Andrew Rima, #2 Exhibit W, #3 Exhibit X, #4 Exhibit Y)(Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 70 REPLY by Defendants AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC to motion for miscellaneous relief, #60 Reply in support of AbbVie's Motion to Exclude Hossein Ardehali and Joshua Sharlin (Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 69 MINUTE entry before the Honorable Matthew F. Kennelly: Plaintiff's motion for leave to file excess pages #68 is granted. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 68 MOTION by Plaintiffs Juliana A. Bunting, Juliana A. Bunting for leave to file excess pages re: Doc. 65 (Opp. to SJ) (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 67 EXHIBIT by Plaintiffs Juliana A. Bunting, Juliana A. Bunting to Summary Judgment Opposition and to Daubert Opposition regarding memorandum in opposition to motion #64 , memorandum in opposition to motion #65 (Attachments: #1 Exhibit A - Hossein Ardehali M.D. deposition transcript, #2 Exhibit B - Hossein Ardehali M.D. general expert report, #3 Exhibit C - Joshua Sharlin Ph.D. expert report, #4 Exhibit D - Joshua Sharlin Ph.D. deposition transcript, #5 Exhibit E - Advisory Committee Testimony of Dr. Monique Falconer, #6 Exhibit F - Garvin K. Chastain M.D. deposition transcript, #7 Exhibit G - FDA Safety Announcement)(O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 65 MEMORANDUM by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting in Opposition to motion for summary judgment, #62 (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 64 MEMORANDUM by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting in Opposition to motion for miscellaneous relief, #60 (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 62 MOTION by Defendants Unimed Pharmaceuticals, LLC, AbbVie Inc., Abbott Laboratories, AbbVie Products LLC for summary judgment (Attachments: #1 Memorandum in Support, #2 Statement of Facts, #3 Exhibit A, #4 Exhibit B, #5 Exhibit C, #6 Exhibit K, #7 Exhibit O)(Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 60 MOTION by Defendants AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC to Exclude Certain Testimony of Hossein Ardehali, M.D., and Joshua Sharlin, Ph. D. (Attachments: #1 Memorandum in Support, #2 Declaration of Andrew Rima, #3 Exhibit C)(Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 59 MINUTE entry before the Honorable Matthew F. Kennelly: The Court sets the following case management deadlines: 1.) Depositions of the plaintiff's case-specific experts are to be completed by 4/19/2023; 2.) Defendants' case-specific Rule 26(a)(2) disclosures are to be made by 5/17/2023 with depositions of defendants' experts to be completed by 6/21/2023; 3.) Summary judgment and Daubert motions are due 7/19/2023; responses are due 8/16/2023; replies are due 8/30/2023. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 58 RESPONSE by Plaintiffs Juliana A. Bunting, Juliana A. Bunting to CMO 194 - Order to Show Cause Regarding Remand (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 57 MDL CASE MANAGEMENT ORDER NO. 192 (Order on AbbVie's motion for summary judgment in Bunting v. AbbVie Inc., No. 15 C 9699), signed by the Honorable Matthew F. Kennelly on 2/7/2023. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 55 REPLY by Defendants AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC to motion for summary judgment #47 and certain exhibits thereto (Attachments: #1 Response to Plaintiffs' Statement of Material Facts, #2 Exhibit S, #3 Exhibit T, #4 Exhibit U, #5 Exhibit V, #6 Exhibit W, #7 Exhibit X, #8 Exhibit Y)(Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 54 EXHIBIT by Plaintiffs Juliana A. Bunting, Juliana A. Bunting regarding response in opposition to motion, #51 (Attachments: #1 Declaration of James Griffin O'Brien, #2 Exhibit F - Kyzatrex Article, #3 Exhibit G - Tlando Article, #4 Exhibit H - Jazento Article, #5 Exhibit I - Jazento Prescibing Information, #6 Exhibit L - Dr. Kochendorfer's Epocrates Printout, #7 Exhibit N - Depo-Testosterone Prescribing Information, #8 Exhibit Q - Prather v. Organon Decision)(O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 52 RULE 56 LR 56.1 Statement by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting regarding motion for summary judgment #47 (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 51 RESPONSE by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Buntingin Opposition to MOTION by Defendants Unimed Pharmaceuticals, LLC, AbbVie Inc., Abbott Laboratories, AbbVie Products LLC for summary judgment #47 (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 50 MINUTE entry before the Honorable Matthew F. Kennelly: In light of the settlement conference in this matter set for 1/24-25/2022, the telephonic status hearing set for 1/25/2022 is vacated. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 49 STATUS Report (Joint) by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 47 MOTION by Defendants Unimed Pharmaceuticals, LLC, AbbVie Inc., Abbott Laboratories, AbbVie Products LLC for summary judgment (Attachments: #1 Statement of Material Facts, #2 Memorandum In Support)(Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 46 MINUTE entry before the Honorable Matthew F. Kennelly: Telephonic status hearing held on 11/15/2021. Defendant's summary judgment motion is to be filed on 1/7/2022. A telephonic status hearing is set for 1/25/2022 at 8:45 a.m. The following call-in number will be used for the hearing: 888-684-8852, access code 746-1053. The parties are directed to file a joint status report by 1/18/2022. Mailed notice. (mma, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 45 STATUS Report (Joint) by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting (Attachments: #1 Exhibit A - Loreto Proposed Order)(O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 44 MINUTE entry before the Honorable Matthew F. Kennelly: At the Court's instance, the telephonic status hearing set for 9/16/2021 is vacated and reset to 11/15/2021 at 8:45 a.m. The following call in number will be used for the hearing: 888-684-8852, access code 746-1053. Counsel should wait for the case to be called before announcing themselves. Plaintiff's request to advance the so-called "second discovery window" under MDL CMO 126, paragraph 15 is deferred until the 11/15/2021 status hearing. The parties are directed to file a joint status report by 11/10/2021. The status report should include: (a) a report on the progress of discovery; (b) for defendants, a summary of any grounds on which they intend to move for summary judgment and to exclude testimony under Daubert; and (c) for both sides, a summary of any depositions or other discovery they would propose to conduct during the "second discovery window" irrespective of whether it is advanced. (mk)[Transferred from ilnd on 11/29/2023.] |
| Filing 43 STATUS Report (Joint) by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 42 MINUTE entry before the Honorable Matthew F. Kennelly: Joint motion for extension of time to complete discovery #41 is granted; deadline is extended to 10/19/2021. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 41 MOTION by Plaintiffs Juliana A. Bunting, Juliana A. Bunting for extension of time to Complete Discovery (Joint) (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 40 MINUTE entry before the Honorable Matthew F. Kennelly: Telephonic status hearing held on 7/8/2021 and continued to 9/16/2021 at 9:15 a.m. The following call in number will be used for the hearing: 888-684-8852, access code 746-1053. The parties are directed to file a joint status report by 9/9/2021. Mailed notice. (mma, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 39 STATUS Report (Joint) by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 38 CASE MANAGEMENT ORDER 186 - ORDER AMENDING THE COMMON BENEFIT ORDER: Signed by the Honorable Matthew F. Kennelly on 6/2/2021. Mailed notice. (mma, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 37 MINUTE entry before the Honorable Matthew F. Kennelly: Plaintiff's unopposed motion to amend the common benefit order is granted. Plaintiff's counsel is directed to submit to Judge Kennelly's proposed order e-mail address a draft order consistent with this ruling for entry on the main MDL docket and in each of the six member cases. The draft order should be approved as to form by the PSC and counsel for the defendants named in the member cases. It may be a single draft order identifying all of the relevant member cases. Mailed notice. (mma, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 35 MOTION by Plaintiffs Juliana A. Bunting, Juliana A. Bunting to amend/correct Common Benefit Order (Unopposed) (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 34 MINUTE entry before the Honorable Matthew F. Kennelly: Telephonic status hearing held on 5/14/2021. The parties provided an update regarding discovery. A telephonic status hearing is set for 7/8/2021 at 9:00 a.m. The following call in number will be used for the hearing: 888-684-8852, access code 746-1053. By no later than 7/1/2021, the parties are directed to file a joint status report on the docket for the individual case. Mailed notice. (mma, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 33 NOTICE by AbbVie Inc. Of Affirmative Defenses (Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 32 MINUTE entry before the Honorable Matthew F. Kennelly: Motion for leave to file notice of affirmative defenses #31 is unopposed and is granted. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 31 MOTION by Defendant AbbVie Inc. for leave to file Notice of Affirmative Defenses (Attachments: #1 Exhibit A - Notice of Affirmative Defenses)(Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 30 ATTORNEY Appearance for Defendants AbbVie Inc., Abbott Laboratories by Edward James Dumoulin (Dumoulin, Edward) [Transferred from ilnd on 11/29/2023.] |
| Filing 29 ATTORNEY Appearance for Defendants AbbVie Inc., Abbott Laboratories by Michael James Casner (Casner, Michael) [Transferred from ilnd on 11/29/2023.] |
| Filing 28 MDL CASE MANAGEMENT ORDER NO. 182 (Scheduling Order for Case Nos. 1:15-cv-9699,1:16-cv-2561, and 1:17-cv-4117), signed by the Honorable Matthew F. Kennelly on 2/10/2021. Telephone status hearing is set for 5/14/2021 at 8:45 AM, using call-in number 888-684-8852, conference code 746-1053. Counsel should wait for the case to be called before announcing themselves. (mk) [Transferred from ilnd on 11/29/2023.] |
| Filing 27 STATUS Report (Joint) by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting (Attachments: #1 Exhibit A - Proposed Scheduling Order)(O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 26 ATTORNEY Appearance for Defendants AbbVie Inc., Abbott Laboratories by Andrew J Rima (Rima, Andrew) [Transferred from ilnd on 11/29/2023.] |
| Filing 25 ATTORNEY Appearance for Defendants AbbVie Inc., Abbott Laboratories by Shayna Susanne Cook (Cook, Shayna) [Transferred from ilnd on 11/29/2023.] |
|
Filing 24
ORDER Seconded Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 30, 2020. All open cases are impacted by this Second Amended General Order. Amended General Order 20-0012, entered on March 17, 2020, and General Order 20-0014, entered on March 20, 2020, are vacated and superseded by this Second Amended General. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/30/2020: Mailed notice. (docket9, ) [Transferred from ilnd on 11/29/2023.]
|
|
Filing 23
ORDER Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on March 16, 2020. All open cases are impacted by this Amended General Order. See attached Order for guidance.Signed by the Honorable Rebecca R. Pallmeyer on 3/16/2020: Mailed notice. (docket1, ) [Transferred from ilnd on 11/29/2023.]
|
| Filing 22 ENTERED JUDGMENT: Pursuant to the Court's order of 8/17/2018 in the MDL 2545 master file, Case No. 14 C 1748 (dkt. no. 2841) final judgment is entered in favor of Besins. Besins Healthcare, Inc and Besins Healthcare, S.A. terminated. Mailed notice. (rp, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 21 MINUTE entry before the Honorable Matthew F. Kennelly: All claims against Actavis, Inc., Actavis Pharma, Inc., Actavis Laboratories UT, Inc., and Anda, Inc. are dismissed without prejudice. Mailed notice. (pjg, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 20 STIPULATION of Dismissal of the Actavis Defendants (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 19 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. AbbVie Products LLC waiver sent on 2/29/2016, answer due 4/29/2016; Unimed Pharmaceuticals, LLC waiver sent on 2/29/2016, answer due 4/29/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 18 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. AbbVie Inc. waiver sent on 2/22/2016, answer due 4/22/2016; Abbott Laboratories waiver sent on 2/22/2016, answer due 4/22/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 17 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. Besins Healthcare Inc. waiver sent on 2/22/2016, answer due 4/22/2016; Besins Healthcare, S.A. waiver sent on 2/22/2016, answer due 4/22/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 16 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. Actavis Laboratories UT, Inc. waiver sent on 2/22/2016, answer due 4/22/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 15 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. Actavis Pharma, Inc. waiver sent on 2/22/2016, answer due 4/22/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 14 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. Actavis, Inc. waiver sent on 2/22/2016, answer due 4/22/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 13 WAIVER OF SERVICE returned executed by Juliana A. Bunting(as Personal Representative of the Estate of Kenneth F. Bunting), Juliana A. Bunting. Anda, Inc. waiver sent on 2/22/2016, answer due 4/22/2016. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Pursuant to minute entry 1469 in Case No. 14 C 1748, defendant Solvay, S.A. is terminated from this case, having been voluntarily dismissed. (las, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 12 STIPULATION of Dismissal OF SOLVAY, S.A. (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 11 MINUTE entry before the Honorable Matthew F. Kennelly: All claims against Actavis plc and Watson Laboratories, Inc., a Nevada corporation are dismissed without prejudice. (pjg, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 10 ATTORNEY Appearance for Defendants Actavis Laboratories UT, Inc., Actavis Pharma, Inc., Actavis, Inc., Anda, Inc. by Jeffrey Francis Peck (Peck, Jeffrey) [Transferred from ilnd on 11/29/2023.] |
| Filing 9 ATTORNEY Appearance for Defendants Actavis Laboratories UT, Inc., Actavis Pharma, Inc., Actavis, Inc., Anda, Inc. by Jeffrey Daniel Geoppinger (Geoppinger, Jeffrey) [Transferred from ilnd on 11/29/2023.] |
| Filing 8 Short Form ANSWER to Complaint with Jury Demand by Actavis Laboratories UT, Inc., Actavis Pharma, Inc., Actavis, Inc., Anda, Inc.(Thomas, Joseph) [Transferred from ilnd on 11/29/2023.] |
| Filing 7 ATTORNEY Appearance for Defendants Actavis Laboratories UT, Inc., Actavis Pharma, Inc., Actavis, Inc., Anda, Inc. by Joseph P Thomas (Thomas, Joseph) [Transferred from ilnd on 11/29/2023.] |
| Filing 6 SHORT FORM ANSWER to Complaint with Jury Demand by AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC(Boisvert, Christopher) [Transferred from ilnd on 11/29/2023.] |
| Filing 5 ATTORNEY Appearance for Defendants AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Unimed Pharmaceuticals, LLC by Christopher Boisvert (Boisvert, Christopher) [Transferred from ilnd on 11/29/2023.] |
| Filing 4 STIPULATION of Dismissal of Defendants Actavis plc and Watson Laboratories, Inc., a Nevada Corporation (Green, Kerry) [Transferred from ilnd on 11/29/2023.] |
| Filing 3 ATTORNEY Appearance for Defendants Actavis Laboratories UT, Inc., Actavis Pharma, Inc., Actavis, Inc., Anda, Inc., Watson Laboratories, Inc. by Kerry Carson Green (Green, Kerry) [Transferred from ilnd on 11/29/2023.] |
| SUMMONS Issued as to Defendants AbbVie Inc., AbbVie Products LLC, Abbott Laboratories, Actavis Laboratories UT, Inc., Actavis Pharma, Inc., Actavis, Inc., Anda, Inc., Besins Healthcare Inc., Besins Healthcare, S.A., SOLVAY, S.A., Unimed Pharmaceuticals, LLC(Bunting 15-9699) (pg, ) [Transferred from ilnd on 11/29/2023.] |
| MEMBER CASE OPENED from Northern District of Illinois; ( 1:15-cv-09699 Juliana A. Bunting as Personal Representative of the Estate of Kenneth F. Bunting et al v. AbbVie Inc. et al / Direct file in ILND). In Re: Testosterone Replacement Therapy Products Liability Litigation (MDL 2545 ) (mr, ) [Transferred from ilnd on 11/29/2023.] |
| Filing 2 ATTORNEY Appearance for Plaintiffs Juliana A. Bunting, Juliana A. Bunting as Personal Representative of the Estate of Kenneth F. Bunting by James Griffin O'Brien (O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| Filing 1 COMPLAINT filed by Juliana A. Bunting, Juliana A. Bunting as Personal Representative of the Estate of Kenneth F. Bunting; Jury Demand. Filing fee $ 400, receipt number 0752-11244684. (Attachments: #1 Civil Cover Sheet)(O'Brien, James) [Transferred from ilnd on 11/29/2023.] |
| CASE ASSIGNED to the Honorable Matthew F. Kennelly. Designated as Magistrate Judge the Honorable Sidney Schenkier. (daj, ) [Transferred from ilnd on 11/29/2023.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Missouri Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
